Henry Schein, Inc. (NASDAQ:HSIC) Holdings Lifted by Mather Group LLC.

Mather Group LLC. grew its position in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 43.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,503 shares of the company’s stock after purchasing an additional 457 shares during the period. Mather Group LLC.’s holdings in Henry Schein were worth $104,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Clarkston Capital Partners LLC grew its position in Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after acquiring an additional 414,748 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Henry Schein in the third quarter valued at approximately $515,000. Olstein Capital Management L.P. boosted its holdings in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after acquiring an additional 16,000 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in shares of Henry Schein by 1,848.9% in the third quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after acquiring an additional 100,006 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on HSIC shares. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Barrington Research upped their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.10.

View Our Latest Stock Analysis on HSIC

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.14% of the stock is owned by insiders.

Henry Schein Trading Down 1.1 %

Shares of NASDAQ HSIC opened at $79.00 on Friday. The company has a market cap of $9.85 billion, a price-to-earnings ratio of 32.51, a P/E/G ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business has a fifty day simple moving average of $73.66 and a 200-day simple moving average of $71.73.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.32 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 4.76 EPS for the current year.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.